Correlation of dose intensity and prognosis in adjuvant chemotherapy: an extended controversy.
Hryniuk
W M
WM
Ontario Cancer Foundation, Hamilton, Ontario, Canada.
D000277:Adjuvants, Pharmaceutic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D015179:Colorectal Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D015201:Meta-Analysis as Topic; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011379:Prognosis; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic
D000277:Adjuvants, Pharmaceutic; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate